chlorpheniramine maleate; pseudoephedrine hydrochloride
PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE (chlorpheniramine maleate; pseudoephedrine hydrochloride) by Ascentage Pharma. Approved for these symptoms due to hay fever, other upper respiratory allergies: runny nose itchy, watery eyes sneezing itching of the nose and 1 more indications. First approved in 1988.
Drug data last refreshed 7h ago · AI intelligence enriched 1w ago
Pseudoephedrine HCl and chlorpheniramine maleate is a combination oral decongestant and first-generation antihistamine available in extended-release capsule form. It is indicated for symptomatic relief of upper respiratory allergies including runny nose, itchy/watery eyes, sneezing, and throat itching due to hay fever and related conditions. The decongestant reduces nasal congestion while the antihistamine blocks histamine-mediated allergic symptoms.
With LOE approaching and limited Part D data visibility, brand teams face declining revenue pressure and workforce contraction as generic penetration accelerates.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Worked on PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE at Ascentage Pharma? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Zero linked job openings and LOE status suggest minimal active hiring on this product; roles that do exist focus on maintaining market share and managing generic transition rather than growth. Career advancement opportunities are constrained; professionals should evaluate this product as a maintenance assignment or stepping stone to pipeline growth assets.